Apr 3, 2023 Press Releases
PDF Version AT-04 demonstrated sub nanomolar binding to Aβ, tau and α-synuclein fibrils AT-04 demonstrated in vivo target engagement and binding to Aβ plaques in the brain AT-07 (AT-04 + Brain Shuttle) demonstrated a 10-fold increase in brain penetration versus AT-04...
Apr 1, 2023 Posters & Publications
AUTHORS: S. Selvarajah1, P. Stocki2, A. Vick1, M. Klein1, N. Angell1, A. Gauhar2, S. Coker2, J. S. Foster3, S. Macy3, A. Williams3, M. Balachandran3, L.J. Rutkowski2, J. Wall3 1Attralus Inc, San Francisco, California, USA 2Ossianix Inc, Stevenage, UK 3University of...
